盘前有料丨住建部部长倪虹：推进收购存量商品房改革；东鹏饮料拟10派25元……重要消息还有这些

Key Points - The article discusses various important news and updates related to the investment landscape, including new stock offerings, economic data, and government policies affecting trade and real estate [2][4][5][6][7][8][11][12][19][20]. Group 1: New Stock Offerings - Jiangnan New Materials has a new stock offering with a subscription code of 732124 and an issue price of 10.54 yuan per share, with a subscription limit of 11,500 shares [2]. Group 2: Trade Policies - The State Council Tariff Commission announced that Canada will impose a 100% tariff on Chinese electric vehicles starting October 1, 2024, and a 25% tariff on Chinese steel and aluminum products starting October 22, 2024. In response, China will impose tariffs on Canadian canola oil, oilseed meal, and peas starting March 20, 2025, and a 25% tariff on Canadian seafood and pork [4]. Group 3: Economic Data - In February 2025, China's consumer price index (CPI) decreased by 0.7% year-on-year, with food and tobacco prices down by 1.9%, contributing to a 0.54 percentage point decline in CPI. The producer price index (PPI) also saw a year-on-year decrease of 2.2% [5]. Group 4: Real Estate and Urban Development - The Minister of Housing and Urban-Rural Development stated that all old residential areas built before 2000 will be included in urban renewal projects, with a focus on improving living conditions and community facilities [6][7]. Group 5: Corporate Announcements - Dongpeng Beverage reported a 63% increase in net profit for 2024, reaching 3.327 billion yuan, and plans to distribute a cash dividend of 2.5 yuan per share [11]. - Guomai Technology announced that its AI-related technologies have not yet generated commercial revenue, and the company is still in the prototype development stage [13]. - Warner Pharmaceutical plans to invest up to 500 million yuan in a new green manufacturing base for high-end raw materials and intermediates [18]. - Nuo Cheng Jianhua presented significant clinical trial results for its treatment of psoriasis at the AAD annual meeting, showing promising efficacy and safety [19].